Lars Havn Gilleberg eier aksjer i 5 selskaper.
- Selskap
- Privatpersoner
- Utenlandsk
Lars Havn Gilleberg
Elac Holding AS
100 %
Profile Management AS
100 %
Triwelig AS
100 %
Oslo Uteliv Drift AS
100 %
Bygdøy Vertshus AS
100 %
Husets Vin AS
100 %
Busma AS
100 %
Ty Production AS
47,3 %
Pretio AS
100 %
Social Club AS
100 %
Mj Ventures AS
100 %
Samare AS
55 %
Iki Oslo AS
50 %
Nordic Hub AS
50 %
Ty Sports AS
40 %
Elliptic Laboratories ASA
<0,1 %
Healthy Pointers AS
100 %
Link Mobility Group AS
100 %
Link Mobility Usa AS
100 %
Link Mobility AS
100 %
Akastor ASA
<0,1 %
Mercury Holdco AS
100 %
Akastor AS
100 %
Rga Energy Holdings AS
100 %
Føn Energy Services AS
36,1 %
Føn Energy Services AS
1,3 %
Aqualis ASA
4,5 %
Aka Sph AS
100 %
Ddw Offshore AS
100 %
Akofs Offshore AS
66,7 %
Ikm Løfteteknikk AS
33 %
Oslotech AS
0,9 %
Sharelab AS
100 %
Sl Seed AS
100 %
Aleap AS
66,7 %
Aleap Ventures AS
100 %
Aleap Invest i AS
40 %
Aleap Fund i AS
5,9 %
Aristeia AS
5,3 %
Age Labs AS
2,6 %
Aeon Biotech AS
10 %
Pacertool AS
1,2 %
Cimon Medical AS
0,6 %
Cimon Medical AS
1 %
Startuplab AS
28,5 %
Startuplab Ventures AS
100 %
Startuplab Vestland AS
100 %
Rocket Asset Management AS
33,3 %
Founders First V AS
30,2 %
Founders First IV AS
19,2 %
6AM Accelerator AS
12,7 %
Startuptrd AS
33,3 %
Vingrip Energy AS
5,4 %
Qrrnt AS
4,4 %
Slidedrain AS
4,3 %
Fornix AS
3,4 %
Headshed AS
2,9 %
Overvinne AS
2,9 %
Bryte AS
1,8 %
Bagid AS
1,8 %
Last Woman Standing AS
10,1 %
Skiwo AS
2,2 %
Lybe Scientific AS
12,9 %
Vilda AS
10,8 %
Osirion AS
9,7 %
Botanist AS
9 %
Masterchannel AS
8,9 %
Infraspace AS
8,5 %
Insert Logic AS
8,4 %
Counting Hero AS
8 %
Versiro AS
7,9 %
Wewillwrite AS
7,8 %
Remarkable Holding AS
1,7 %
Remarkable Invest AS
97,5 %
Remarkable Holding AS
4,9 %
Oslo Science Park AS
26,4 %
Ciens Eiendom AS
100 %
Skiwo AS
13 %
Remarkable Holding AS
5,1 %
Remarkable Invest AS
97,5 %
Remarkable Holding AS
4,9 %
Northern.tech Holding AS
3,3 %
Northern.tech AS
100 %
Oslo Science Park III AS
14,8 %
Aleap Fund i AS
9,1 %
Thelper AS
5,2 %
Oslo Science Park II AS
8,5 %
Gaustadalleen 21 AS
100 %
Forskningsparken Energi AS
47,6 %
Akastor ASA
0,5 %
Nykode Therapeutics ASA
<0,1 %